retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial hormone receptor for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Triple Agonism Based Therapies for

Some research suggests that taking 500 to 510 mg of L-carnitine daily may help treat narcolepsy, a sleeping condition characterized by abnormal sleeping patterns

The abrupt cessation of GLP-1R agonists in individuals with metabolic disorders may lead to adverse effects, as seen in a case where a patient developed IIH after discontinuing duraglutide [29]

Recently, novel drugs combining GLP-1R agonism with other options, beyond the forementioned dual or triple agonist drugs, are being developed to maximize efficacy and minimize adverse effects in obesity and diabetes treatment

GLP-1R agonists protect against Alzheimers disease by rewiring energy regulation